Sirona Biochem releases CEO Letter to Shareholders
Clinical trial results expected Q1 2019
Vancouver, British Columbia - January 30, 2019 - Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (the Company) is pleased to provide a corporate update today from the Companys CEO, Dr. Howard Verrico regarding ...
↧